Investigating the financial burden of cancer drugs on Medicare patients
The rising cost of targeted oral anticancer medications may put a substantial financial burden on individual patients enrolled in Medicare's prescription drug benefit program, Part D, according to a study published in the ...
Jul 18, 2017
0
1